Page last updated: 2024-12-04

itaconic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

itaconic acid : A dicarboxylic acid that is methacrylic acid in which one of the methyl hydrogens is substituted by a carboxylic acid group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID811
CHEMBL ID359159
CHEBI ID30838
SCHEMBL ID21523
MeSH IDM0046626

Synonyms (80)

Synonym
bdbm50036216
2-methylene-butanedioic acid
nsc-3357
butanedioic acid, methylene-
nsc3357 ,
succinic acid, methylene-
CHEBI:30838 ,
2-methylidenebutanedioic acid
2-methylenebutanedioic acid
PROBES1_000076
PROBES2_000247
2-methylene,1,4-butanedioic acid (itaconic acid)
2-methylenesuccinic acid
butanedioic acid, 2-methylene-
inchi=1/c5h6o4/c1-3(5(8)9)2-4(6)7/h1-2h2,(h,6,7)(h,8,9
2-propene-1,2-dicarboxylic acid
itaconic acid
methylenesuccinic acid
C00490
methylenebutanedioic acid
ITACONATE ,
97-65-4
propylenedicarboxylic acid
itaconic acid, >=99%
hsdb 5308
einecs 202-599-6
nsc 3357
ai3-16901
NCISTRUC1_001783
NCIOPEN2_004822
NCISTRUC2_000502
53EEC7A3-4846-4588-BBC9-CB8846377B96
2-methylene-succinic acid
CHEMBL359159 ,
AKOS000118895
BMSE000137
succinic acid, methylene- (8ci)
M0223
LMFA01170063
NCGC00249019-01
tox21_303071
NCGC00257141-01
dtxcid006608
cas-97-65-4
dtxsid2026608 ,
tox21_201299
NCGC00258851-01
BBL011584
STL163322
25119-64-6
q4516562yh ,
ec 202-599-6
unii-q4516562yh
FT-0627543
itaconic acid [mi]
itaconic acid [inci]
S3095
2-methylenebutanedioate
SCHEMBL21523
2-methylenesuccinic acid #
Z57127539
mfcd00004260
butanedioic acid,ethylidene-,(e)-(9ci)
ITN ,
F2191-0234
itaconic acid, analytical standard
methylene-butanedioicaci
2-methylenesuccinate
2-hydroxy-3-naphthoyl-2-naphthylamine
methylenebutanedioate
methylenesuccinate
2-propene-1,2-dicarboxylate
propylenedicarboxylate
HY-Y0520
AS-11816
Q903311
CS-0015302
SB67306
EN300-18045
E80791

Research Excerpts

Overview

Itaconic acid (IA) is a biologically based unsaturated dicarboxylic acid secreted by mammalian cells. Current methods for IA production based on Aspergillus terreus fermentation are limited in terms of process efficiency and productivity.

ExcerptReferenceRelevance
"Itaconic acid (IA) is a biologically based unsaturated dicarboxylic acid secreted by mammalian cells. "( Effects of dietary supplementation with itaconic acid on the growth performance, nutrient digestibility, slaughter variables, blood biochemical parameters, and intestinal morphology of broiler chickens.
Dong, W; Li, L; Liu, H; Tao, L; Yang, G; Zhang, Y; Zhao, Y; Zhu, X, 2022
)
2.43
"Itaconic acid (IA) is a versatile platform chemical widely used for the synthesis of various polymers and current methods for IA production based on Aspergillus terreus fermentation are limited in terms of process efficiency and productivity. "( Synergistic effects on itaconic acid production in engineered Aspergillus niger expressing the two distinct biosynthesis clusters from Aspergillus terreus and Ustilago maydis.
Cao, W; Guo, Y; Liu, H; Wang, Y, 2022
)
2.47
"Itaconic acid (IA) is a high value-added compound that is expected to be an alternative to petroleum-based chemicals."( Metabolic engineering of Schizosaccharomyces pombe for itaconic acid production.
Fujie, N; Hirata, Y; Ito, M; Kishida, M; Kondo, A; Tanaka, T, 2022
)
1.69
"Itaconic acid (IA) serves as a prominent building block for polyamides as sustainable material. "( High-level itaconic acid (IA) production using engineered Escherichia coli Lemo21(DE3) toward sustainable biorefinery.
Diankristanti, PA; Effendi, SSW; Hsiang, CC; Ng, IS, 2023
)
2.74
"Itaconic acid (IA) is a value-added chemical currently produced by Aspergillus terreus from edible glucose and starch but not from inedible lignocellulosic biomass owing to the high sensitivity to fermentation inhibitors present in the hydrolysate of lignocellulosic biomass. "( Enhanced production of itaconic acid from enzymatic hydrolysate of lignocellulosic biomass by recombinant Corynebacteriumglutamicum.
Elkasaby, T; Hanh, DD; Kawaguchi, H; Kondo, A; Ogino, C; Tsuge, Y, 2023
)
2.66
"Itaconic acid is a metabolite from the citric acid cycle of the host and shows volatile odor-reducing effects during animal production operations."( Microbiome-metabolomics analysis reveals abatement effects of itaconic acid on odorous compound production in Arbor Acre broilers.
Li, L; Liu, H; Yang, G; Zhang, Y; Zhu, X, 2023
)
1.87
"Itaconic acid is an important bio-based chemical. "( Evaluating the potential of semi-continuous itaconic acid fermentation by Aspergillus terreus: operational profile and experiences.
Bélafi-Bakó, K; Hülber-Beyer, É; Komáromy, P; Nemestóthy, N; Rózsenberszki, T, 2023
)
2.61
"Itaconic acid (IA) is a naturally occurring dicarboxylic acid with applications in the manufacture of polymers. "( Mitochondrial carriers of Ustilago maydis and Aspergillus terreus involved in itaconate production: same physiological role but different biochemical features.
Agrimi, G; Blank, LM; Fiermonte, G; Gorgoglione, R; Messina, E; Palmieri, L; Scarcia, P; Wierckx, N, 2020
)
2
"Itaconic acid is an immunoregulatory metabolite produced by macrophages in response to pathogen invasion. "(
Joerger, RD, 2020
)
2
"Itaconic acid is a naturally occurring compound with a Michael acceptor moiety, a key structural feature in several anticancer and antiviral drugs, responsible for the covalent binding of a drug to the cysteine residue of a specific protein."( Itaconic acid hybrids as potential anticancer agents.
Beus, M; Perković, I; Persoons, L; Schols, D; Zorc, B, 2022
)
2.89
"Itaconic acid is an excellent polymeric precursor with wide range of industrial applications. "( Engineering efficient production of itaconic acid from diverse substrates in Escherichia coli.
Chang, P; Chen, GS; Chu, HY; Lu, KW; Shen, CR, 2017
)
2.17
"Itaconic acid (IA) is a building block platform chemical which is currently produced industrially from glucose by fermentation with Aspergillus terreus. "( Mannose and galactose as substrates for production of itaconic acid by Aspergillus terreus.
Kennedy, GJ; Saha, BC, 2017
)
2.15
"Itaconic acid (IA) is a building block platform chemical that is currently produced industrially from glucose by fermentation with Aspergillus terreus. "( Ninety six well microtiter plate as microbioreactors for production of itaconic acid by six Aspergillus terreus strains.
Kennedy, GJ; Saha, BC, 2018
)
2.16
"Itaconic acid is a five-carbon dicarboxylic acid with an unsaturated alkene bond, frequently used as a building block for the industrial production of a variety of synthetic polymers. "( High oxygen tension increases itaconic acid accumulation, glucose consumption, and the expression and activity of alternative oxidase in Aspergillus terreus.
Ág, N; Fekete, E; Flipphi, M; Karaffa, L; Kolláth, IS; Kovács, B; Kubicek, CP; Molnár, ÁP; Németh, Z; Sándor, E; Soós, Á, 2018
)
2.21
"Itaconic acid, which is a promising organic acid in synthetic polymers and some base-material production, has been produced by Aspergillus terreus fermentation at a high cost. "( Efficient Itaconic acid production via protein-protein scaffold introduction between GltA, AcnA, and CadA in recombinant Escherichia coli.
Eom, GT; Hong, SH; Somasundaram, S; Tran, KT, 2019
)
2.36
"Itaconic acid is an organic compound that inhibits isocitrate lyase, the key enzyme of the glyoxylate shunt, a pathway essential for bacterial growth under specific conditions."( Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production.
Balling, R; Binz, T; Buttini, M; Cordes, T; Ghelfi, J; Goldmann, O; Hiller, K; Linster, CL; Medina, E; Michelucci, A; Pailot, A; Rausell, A; Reiling, N; Tallam, A; Wegner, A, 2013
)
1.34
"Itaconic acid is an unsaturated dicarboxylic acid which has a high potential as a biochemical building block. "( Targeting enzymes to the right compartment: metabolic engineering for itaconic acid production by Aspergillus niger.
Blumhoff, ML; Mattanovich, D; Sauer, M; Steiger, MG, 2013
)
2.07
"Itaconic acid is an important industrial building block and is produced by the filamentous fungi Aspergillus terreus. "( Filamentous fungi in microtiter plates-an easy way to optimize itaconic acid production with Aspergillus terreus.
Hevekerl, A; Kuenz, A; Vorlop, KD, 2014
)
2.08
"Itaconic acid is a naturally produced organic acid with diverse applications as a replacement for petroleum derived products. "( Metabolic engineering of Yarrowia lipolytica for itaconic acid production.
Alper, HS; Blazeck, J; Hill, A; Jamoussi, M; Miller, J; Pan, A, 2015
)
2.11
"Itaconic acid is an important biomass-derived chemical building block but has also recently been identified as a metabolite produced in mammals, which has antimicrobial activity. "( Ustilago maydis produces itaconic acid via the unusual intermediate trans-aconitate.
Blank, LM; Bölker, M; Buckel, W; Friedrich, A; Geiser, E; Przybilla, SK; Wierckx, N, 2016
)
2.18
"Itaconic acid is a high potential platform chemical which is currently industrially produced by Aspergillus terreus. "( Model-based metabolic engineering enables high yield itaconic acid production by Escherichia coli.
Bettenbrock, K; Harder, BJ; Klamt, S, 2016
)
2.13
"Itaconic acid (IA) is a dicarboxylic acid included in the US Department of Energy's (DOE) 2004 list of the most promising chemical platforms derived from sugars. "( Itaconic and Fumaric Acid Production from Biomass Hydrolysates by Aspergillus Strains.
Avérous, L; Jiménez-Quero, A; Marchioni, E; Phalip, V; Pollet, E; Zhao, M, 2016
)
1.88
"Itaconic acid is a promising chemical that has a wide range of applications and can be obtained in large scale using fermentation processes. "( Downstream process development in biotechnological itaconic acid manufacturing.
de Carvalho, JC; Magalhães, AI; Medina, JDC; Soccol, CR, 2017
)
2.15
"Itaconic acid serves as a precursor in polymer industry, whereas lovastatin found its place in the pharmaceutical market as a cholesterol-lowering statin drug and a precursor for semisynthetic statins."( Production of lovastatin and itaconic acid by Aspergillus terreus: a comparative perspective.
Bizukojc, M; Boruta, T, 2017
)
1.47
"Itaconic acid is an important metabolite produced by macrophages after stimulation with LPS. "( Dimethyl Itaconate Is Not Metabolized into Itaconate Intracellularly.
Burant, CF; ElAzzouny, M; Evans, CR; Gallagher, KA; Martin, BR; Olson, LL; Tanga, MJ; Tom, CT, 2017
)
1.9
"Itaconic acid is a promising organic acid and is commercially produced by submerged fermentation of Aspergillus terreus. "( Process development of itaconic acid production by a natural wild type strain of Aspergillus terreus to reach industrially relevant final titers.
Hevekerl, A; Krull, S; Kuenz, A; Prüße, U, 2017
)
2.21
"Itaconic acid (IA) is an unsaturated dicarbonic organic acid. "( Biotechnological production of itaconic acid.
Vorlop, KD; Willke, T, 2001
)
2.04

Effects

Itaconic acid has economic potential as a commodity biochemical for the sugar industry, but its production is limited due to high production costs. It has been declared to be one of the most promising and flexible building blocks.

ExcerptReferenceRelevance
"Itaconic acid has economic potential as a commodity biochemical for the sugar industry, but its production is limited due to high production costs. "( Process design and economic analysis of a biorefinery co-producing itaconic acid and electricity from sugarcane bagasse and trash lignocelluloses.
Görgens, JF; Haigh, KF; Nieder-Heitmann, M, 2018
)
2.16
"Itaconic acid (ITA) has recently been identified as an antimicrobial metabolite in mammalian immune cells. "( Targeted metabolomics to investigate antimicrobial activity of itaconic acid in marine molluscs.
Alfaro, AC; Van Nguyen, T, 2019
)
2.2
"Itaconic acid, which has been declared to be one of the most promising and flexible building blocks, is currently used as monomer or co-monomer in the polymer industry, and produced commercially by Aspergillus terreus. "( Improving itaconic acid production through genetic engineering of an industrial Aspergillus terreus strain.
Huang, X; Li, JJ; Li, X; Li, Y; Lu, X, 2014
)
2.25
"Itaconic acid (IA) has been identified as one of the top twelve building block chemicals which have high potential to be produced by biotechnological means."( Rewiring a secondary metabolite pathway towards itaconic acid production in Aspergillus niger.
Brickwedde, A; Caspers, M; Hossain, AH; Li, A; Overkamp, K; Punt, PJ; Wilms, L, 2016
)
1.41

Toxicity

ExcerptReferenceRelevance
" Therefore it might be used as a safe candidate for drug delivery system."( Preliminary assessment of the safety evaluation of novel pH-sensitive hydrogel.
Dong, K; Gao, Y; Li, WF; Wang, K; Xing, JF, 2012
)
0.38
" Compared to the control groups, there were no important adverse effects in the variables of hematology routine test and serum chemistry analysis both in male or female treatment group."( Synthesis, characterization, and acute oral toxicity evaluation of pH-sensitive hydrogel based on MPEG, poly(ε-caprolactone), and itaconic acid.
Luo, F; Qian, Z; Song, J; Tan, L; Xu, X, 2013
)
0.59

Bioavailability

ExcerptReferenceRelevance
"In this study, sustained release superabsorbent copolymer particles have been prepared and analyzed to increase bioavailability of orally administered risedronate sodium."( RELATIVE BIOAVAILABILITY OF RISEDRONATE SODIUM ADMINISTERED IN SUPERABSORBENT COPOLYMER PARTICLES VERSUS ORAL SOLUTION TO NORMAL HEALTHY RABBITS.
Abbas, N; Bukhari, NI; Hussain, T; Karim, S; Shahzad, MK, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" Undesirable effects of cancer therapeutics are a major reason for drug-associated toxicity, which confounds drug dosing and efficacy."( The promise and peril of targeting cell metabolism for cancer therapy.
Weiss, JM, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
dicarboxylic acidAny carboxylic acid containing two carboxy groups.
olefinic compoundAny organic molecular entity that contains at least one C=C bond.
dicarboxylic fatty acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Purine Nucleotides De Novo Biosynthesis2945
Purine Nucleotides De Novo Biosynthesis 22945

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency13.95030.000221.22318,912.5098AID743042
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency56.01830.001024.504861.6448AID743215
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-citrate synthase Rattus norvegicus (Norway rat)Ki1,000.00000.15004.75718.0000AID32395
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID1685610Binding affinity to wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) in presence of Mg2+ and glyoxylate by NMR binding analysis2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID32395Reversible binding potential for rat ATP-Citrate Lyase as carbon-carbon bond cleavage activity in citrate substrate1995Journal of medicinal chemistry, Feb-03, Volume: 38, Issue:3
Synthesis of novel thiol-containing citric acid analogues. Kinetic evaluation of these and other potential active-site-directed and mechanism-based inhibitors of ATP citrate lyase.
AID1685613Covalent inhibition of wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) using DL-isocitrate as substrate measured after 1 hr by UV-Vis spectrophotometric analysis2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1685601Binding affinity to wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 (Ala170-Lys197) expressed in Escherichia coli BL21 (DE3) assessed as covalent adduct formation at 1 mM incubated overnight in presence2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1685604Binding affinity to wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) in presence of MgCl2 by NMR binding analysis2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1685611Binding affinity to wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) in presence of glyoxylate by NMR binding analysis2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1685612Binding affinity to wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) assessed as covalent adduct formation in presence of glyoxylate by NMR binding analysis2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1685600Binding affinity to N-terminal polyhis-tagged Mycobacterium tuberculosis ICL1 C191S mutant expressed in Escherichia coli BL21 (DE3) assessed as compound-protein covalent adduct formation by measuring molecular mass at 1 mM after 12 hrs in presence of MgCl2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID258399Inhibition of p53-HDM2 interaction at 50 ug/ml2006Bioorganic & medicinal chemistry letters, Jan-01, Volume: 16, Issue:1
Hexylitaconic acid: a new inhibitor of p53-HDM2 interaction isolated from a marine-derived fungus, Arthrinium sp.
AID1685608Binding affinity to wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) assessed as covalent adduct formation at 1 mM measured after 5 hrs in presence of Mg2+ by LC-2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1685607Binding affinity to wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) assessed as covalent adduct formation at 1 mM measured after 75 mins in presence of Mg2+ by L2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1411952Binding affinity to Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21(DE3) assessed as melting temperature at 1 mM in presence of MgCl2 by SYPRO orange dye based fluorescence assay (Rvb = 43 degC)2017MedChemComm, Nov-01, Volume: 8, Issue:11
Development of NMR and thermal shift assays for the evaluation of
AID1685609Binding affinity to wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) assessed as covalent adduct formation at 1 mM measured after 1 min in presence of Mg2+ and gl2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1685602Binding affinity to recombinant Mycobacterium tuberculosis CDC1551 ICL2 (Cys215-Arg233) expressed in Escherichia coli BL21 (DE3) LOBSTR assessed as covalent adduct formation at 1 mM incubated overnight in presence of Mg2+ followed by trypsin protease dige2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1411949Inhibition of Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21(DE3) using DL-isocitrate as substrate incubated for 25 mins in presence of MgCl2 by 1H NMR method2017MedChemComm, Nov-01, Volume: 8, Issue:11
Development of NMR and thermal shift assays for the evaluation of
AID32394Irreversible inactivation of rat ATP-Citrate Lyase; nd=not detectable1995Journal of medicinal chemistry, Feb-03, Volume: 38, Issue:3
Synthesis of novel thiol-containing citric acid analogues. Kinetic evaluation of these and other potential active-site-directed and mechanism-based inhibitors of ATP citrate lyase.
AID384271Inhibition of Candida albicans isocitrate lyase2008Journal of natural products, May, Volume: 71, Issue:5
Dihydroxystyrene metabolites from an association of the sponges Poecillastra wondoensis and Jaspis sp.
AID1685599Binding affinity to wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) assessed as compound-protein covalent adduct formation by measuring molecular mass at 1 mM af2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1411950Inhibition of Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21(DE3) at 100 uM using DL-isocitrate as substrate incubated for 25 mins in presence of MgCl2 by 1H NMR method2017MedChemComm, Nov-01, Volume: 8, Issue:11
Development of NMR and thermal shift assays for the evaluation of
AID383181Inhibition of Candida albicans isocitrate lyase2008Journal of natural products, Apr, Volume: 71, Issue:4
Sesterterpenoids from the sponge Sarcotragus sp.
AID1685605Binding affinity to N-terminal polyhis-tagged Mycobacterium tuberculosis ICL1 C191S mutant expressed in Escherichia coli BL21 (DE3) in presence of MgCl2 by NMR binding analysis2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1685606Binding affinity to wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) in absence of Mg2+ by NMR binding analysis2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
AID1685603Binding affinity to wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) assessed as compound-protein covalent adduct formation at 1 mM in absence of Mg2+ by LC-MS an2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (521)

TimeframeStudies, This Drug (%)All Drugs %
pre-199031 (5.95)18.7374
1990's13 (2.50)18.2507
2000's57 (10.94)29.6817
2010's213 (40.88)24.3611
2020's207 (39.73)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.64 (24.57)
Research Supply Index6.27 (2.92)
Research Growth Index5.40 (4.65)
Search Engine Demand Index97.10 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (58.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.19%)5.53%
Reviews53 (10.06%)6.00%
Case Studies0 (0.00%)4.05%
Observational2 (0.38%)0.25%
Other471 (89.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]